SELVITA S.A. SER.B ZY-80
Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational re… Read more
Market Cap & Net Worth: SELVITA S.A. SER.B ZY-80 (787)
SELVITA S.A. SER.B ZY-80 (F:787) has a market capitalization of $175.60 Million (€171.07 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #16883 globally and #1753 in its home market, demonstrating a -1.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SELVITA S.A. SER.B ZY-80's stock price €9.32 by its total outstanding shares 18355474 (18.36 Million).
SELVITA S.A. SER.B ZY-80 Market Cap History: 2021 to 2026
SELVITA S.A. SER.B ZY-80's market capitalization history from 2021 to 2026. Data shows change from $330.85 Million to $175.60 Million (-5.44% CAGR).
SELVITA S.A. SER.B ZY-80 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SELVITA S.A. SER.B ZY-80's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 787 by Market Capitalization
Companies near SELVITA S.A. SER.B ZY-80 in the global market cap rankings as of March 18, 2026.
Key companies related to SELVITA S.A. SER.B ZY-80 by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
SELVITA S.A. SER.B ZY-80 Historical Marketcap From 2021 to 2026
Between 2021 and today, SELVITA S.A. SER.B ZY-80's market cap moved from $330.85 Million to $ 175.60 Million, with a yearly change of -5.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €175.60 Million | -5.67% |
| 2025 | €186.15 Million | -10.99% |
| 2024 | €209.14 Million | -18.14% |
| 2023 | €255.49 Million | -22.95% |
| 2022 | €331.61 Million | +0.23% |
| 2021 | €330.85 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of SELVITA S.A. SER.B ZY-80 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $175.60 Million USD |
| MoneyControl | $175.60 Million USD |
| MarketWatch | $175.60 Million USD |
| marketcap.company | $175.60 Million USD |
| Reuters | $175.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.